Wellth

Somewhere right now, a phone buzzes

Awoman in her sixties picks it up. She points the camera at a small pile of pills, taps once, and gets on with her morning. It takes nine seconds. For doing it, she keeps a few dollars she would otherwise lose. Multiply that small moment by tens of millions and you have Wellth - a digital health company that has quietly turned the most boring problem in medicine into a business that health plans now compete to buy.

Wellth is not a wearable. It is not a chatbot promising to diagnose your rash. It is something less glamorous and far more useful: a daily nudge, backed by behavioral economics, that gets the highest-risk patients in America to actually follow their care plans. The company calls it "Daily Care Motivation." Everyone else calls it the thing that finally works.

Medicine that never gets taken

Here is an awkward fact the pharmaceutical industry would rather you skip: roughly half of patients with chronic conditions don't take their medications as prescribed. The prescriptions are written. The drugs are proven. And then nothing happens, because life is busy and a future heart attack is an abstraction while breakfast is not.

The cost of this gap is enormous - hundreds of billions of dollars a year in avoidable hospital visits, plus a great deal of human suffering that no spreadsheet captures. For decades the standard response was the reminder: a text, a pill box, a nurse's phone call. Reminders assume the problem is forgetting. Often the problem is motivation, and you cannot remind someone into caring.

That is the tension Wellth lives inside. The medicine works. The patients want to be well. And still the daily action doesn't happen. Close that gap and you don't just sell software - you change outcomes that the entire value-based care system is graded on.

A wager on loss aversion

Matt Loper studied Biological Engineering at MIT, then went to Goldman Sachs as a healthcare banker and on to the investment firm OrbiMed. He had watched relatives struggle to keep Type 2 diabetes in check - the kind of front-row seat that makes a statistic feel personal. In 2014 he and co-founder Alec Zopf, who became CTO, started Wellth on a contrarian idea borrowed from behavioral economics.

The idea: people hate losing something far more than they enjoy gaining it. So instead of dangling a reward you might earn someday, give members a small balance up front - and let them lose a little each time they skip a daily action. Snap a photo of your meds, your balance is safe. Miss it, and you feel the sting. It sounds almost too simple. That is usually how the good ideas dress.

The bet was that a few dollars, framed as something to keep rather than something to win, would move behavior where clinical urgency could not. The next decade was spent proving it - and, more importantly, proving it to the people who write the checks.

Eleven years, one stubborn habit

Nine seconds, every day

The Wellth app is deliberately unimpressive to look at, which is the point. A member sees the day's actions: take this medication, check your blood pressure, measure your glucose, show up to that appointment, finish that lab. Each one is confirmed with a quick photo check-in - increasingly verified by AI image recognition - and tied to a small financial incentive that behaves like something you can lose.

What makes it unusual is that members enjoy it. The experience borrows the daily-streak feel of consumer apps rather than the clipboard feel of clinical software. It works in multiple languages. And because it asks for nine seconds, not nine steps, the people who most need it - older, sicker, often juggling several conditions - can actually keep up.

The numbers do the talking

Behavioral theories are cheap. Wellth's case rests on what happens once real members start checking in - and the figures it reports are the kind that make a health plan's actuary sit up.

The customers are the proof, too. Wellth sells to Medicare Advantage and D-SNP plans, Medicaid plans, providers, ACA Marketplace plans, and employers - the corners of the system holding the highest-need, highest-cost populations. Partners report a 2-4x return on cost reduction and 4+ Star Ratings across Medicare Part C and D measures, the scores that decide a plan's bonus payments. Investors noticed: New York Life Ventures, Comcast Ventures, SignalFire, FCA Venture Partners and Mercato Partners have all put money in.

There is a tidy detail that says more than any pitch deck. Wellth's chief operating officer, John Snyder, was a Wellth customer before he joined the company. When the person who bought your product comes to run your operations, the demo is over.

A relationship, not a campaign

Most healthcare outreach is a campaign: a burst of calls before an audit, a flurry of mailers at year-end. Wellth's framing is different and a little stubborn. It wants a daily relationship with every member - the kind built in small, repeated moments rather than big, expensive interventions.

It is an unfashionable idea in a market addicted to one-time fixes. Chronic disease is not a one-time problem, so a one-time solution was always going to lose. Wellth's contribution is to treat the daily-ness as the whole game - to make the unglamorous act of showing up, again, the product itself.

The buzz that keeps going

The Series C money is pointed at two things: more health plans, and generative AI that personalizes each member's daily journey rather than handing everyone the same checklist. If that works, the nine-second check-in gets smarter about who you are - what you'll do, what you'll skip, what nudge lands for you specifically.

The stakes are not abstract. As more of healthcare moves to value-based contracts, where plans are paid for outcomes instead of visits, the company that reliably moves daily behavior owns a piece of leverage the rest of the system has chased for years. Wellth is betting the future of care is not a dramatic intervention. It is a habit.

So go back to that woman with the phone. A few years ago she was a name on a non-adherence report, a risk score someone worried about quarterly. This morning she pointed a camera at her pills, kept her few dollars, and went to make breakfast. The hospital visit that didn't happen doesn't send a thank-you note. But it is the whole point - and increasingly, it is the business.